News Sentiment

ALDX sentiment intelligence

Aldeyra The news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 48 Balanced news tone 34 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 2.07 Week of 10 Jul 2026
Weighted tone 48/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

88/100 classification confidence.

Company focus 26

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend inactive

-8.8% over one week, +17.6% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Aldeyra Therapeutics (NASDAQ: ALDX) advances FDA dialogue on reproxalap NDA

Market Reaction

Price moving ahead of tone

63/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 88/100 classification
One-week reaction -8.8% Price reacting lower
Trend fit Trend inactive 17.6% over four weeks
Fair value -51.9% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 2
Neutral 29
Negative 3

Relevance

Why the article matched

Direct first
Direct company coverage 26
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Market source 10
simplywall.st 7
Stocktwits 3
Stock Titan 2
MarketBeat 2
Business Wire 2
Seeking Alpha 1
MT Newswires 1

Event Lens

What the news is about

Classified themes
Market update 25
Earnings 8
Regulatory and legal 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-34 of 34